Open AccessTNF-Alpha Blockers in Inflammatory Bowel Diseases: Practical Recommendations and a User’s Guide: An Update
Author(s) -
Marianne Vullièmoz,
Stephan Brand,
Pascal Juillerat,
Christian Mottet,
Shomron BenHorin,
Pierre Michetti
Publication year - 2020
Publication title -
digestion
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.882
H-Index - 75
eISSN - 1421-9867
pISSN - 0012-2823
DOI - 10.1159/000506898
Subject(s) - inflammatory bowel diseases , inflammatory bowel disease , medicine , alpha (finance) , tumor necrosis factor alpha , gastroenterology , pharmacology , intensive care medicine , surgery , disease , construct validity , patient satisfaction
Anti-tumour necrosis factor-alpha (anti-TNF) antagonists have been the mainstay in the treatment of inflammatory bowel diseases (IBDs) for over 20 years.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom